Note: Pharma funds studies. Doctor participate in the studies. Journals publish the studies. Medical schools teach the studies. New doctors believe the studies. Ad nauseam.
The disconnect continues. Readers who fully understand that a doctor with a vested financial interest might skew a study to his or her benefit regarding a drug or medical device are told this never, ever happens in medical journals regarding vaccination. It's patently absurd thinking. The truth is, money talks, safety walks. Profits before patients. Often. You can't read the entire article because of the paywall unless you are a subscriber. We are not NYT subscribers. Over the years, they have shown little interest in reporting the truth about autism and vaccine injury. The one "exemption" they approve of, apparently. Yes, the photo is through the looking glass....
What These Medical Journals Don’t Reveal: Top Doctors’ Ties to Industry
This article was reported and written in collaboration with ProPublica, the nonprofit journalism organization.
One is dean of Yale’s medical school. Another is the director of a cancer center in Texas. A third is the next president of the most prominent society of cancer doctors.
These leading medical figures are among dozens of doctors who have failed in recent years to report their financial relationships with pharmaceutical and health care companies when their studies are published in medical journals, according to a review by The New York Times and ProPublica and data from other recent research.
Dr. Howard A. “Skip” Burris III, the president-elect of the American Society of Clinical Oncology, for instance, declared that he had no conflicts of interest in more than 50 journal articles in recent years, including in the prestigious New England Journal of Medicine.